Clinical Trial Update: An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer [Phase 2]

View source ↗

Summary

Open-label Phase II trial evaluating continuous low-irradiance photodynamic therapy with Verteporfin (Visudyne) for cutaneous metastases of metastatic breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Verteporfin (Visudyne) (verteporfin)

Snippet

Sponsor: Rogers Sciences Inc. | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN